According to Vaxart's latest financial reports and stock price the company's current Operating Margin is -11,079.40%. At the end of 2021 the company had an Operating Margin of -7,888.23%.
Year | Operating Margin | Change |
---|---|---|
2021 | -7,888.23% | 897.93% |
2020 | -790.46% | 329.39% |
2019 | -184.09% | -57.22% |
2018 | -430.34% | 31.62% |
2017 | -326.97% | 19.72% |
2016 | -273.12% | 249.93% |
2015 | -78.05% | 374.51% |
2014 | -16.45% | -35.74% |
2013 | -25.60% | |
2011 | -64.23% | 2434.95% |
2010 | -2.53% | -98.58% |
2009 | -178.54% | |
2006 | -59.95% | -49.92% |
2005 | -119.71% | 438.11% |
2004 | -22.25% | 192.34% |
2003 | -7.61% | -658.54% |
2002 | 1.36% | -97.24% |
2001 | 49.42% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -234,760.00% | 2,018.89% | Bahamas |
NRC Health
NRC | 32.86% | -100.30% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.